• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以及B细胞非霍奇金淋巴瘤病例中的易位。

and Translocation in B-cell Non-Hodgkin Lymphoma Cases.

作者信息

Salam Dayang Sharyati Datu Abdul, Thit Ei Ei, Teoh Siew Hoon, Tan Soo Yong, Peh Suat Cheng, Cheah Shiau-Chuen

机构信息

Faculty of Medicine and Health Sciences, UCSI University, Kuala Lumpur, Malaysia.

Advanced Molecular Pathology Laboratory, SingHealth Tissue Repository, Singapore.

出版信息

J Cancer. 2020 Jan 1;11(1):190-198. doi: 10.7150/jca.36954. eCollection 2020.

DOI:10.7150/jca.36954
PMID:31892985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6930405/
Abstract

, and genes are the most commonly oncogenes involved in B-Cell lymphomas. Translocations of these oncogenes are associated with an aggressive clinical course. This study aims to elucidate the patterns of , and gene aberrations among Malaysian B-cell Non-Hodgkin Lymphoma (NHL) using fluorescence hybridization (FISH). Eighty-one B-cell NHL tissue blocks were retrieved between the year 2011 to 2015 and investigated using immunohistochemistry and interphase FISH dual colour break-apart probes of , , and . A significant difference was detected between the nodal and extranodal sites in all the (p=0.01), (p=0.03) and (p=0.006) cases except for (p=0.2). Our study showed that had the highest gene translocation while had the most mixed aberrations of gain copies and translocation, however no mixed aberrations of gain copies and translocation was found in . None of the mixed gain copies and translocation was found in any of the germinal centre B-cell (GCB) subtype of Diffuse Large B-cell Lymphoma, however, five were found in and gene in the non-GCB subtype; while mixed gain copies and translocation cases of gene was found in the Follicular Lymphoma cases only. The study found interesting findings of , and gene aberrations between nodal and extranodal sites. This information might benefit future study in predicting prognosis and determine effective therapeutic strategies in the multi-ethnic populations of Malaysia as well as the Asian population.

摘要

、 和 基因是B细胞淋巴瘤中最常见的致癌基因。这些致癌基因的易位与侵袭性临床病程相关。本研究旨在利用荧光原位杂交(FISH)阐明马来西亚B细胞非霍奇金淋巴瘤(NHL)中 、 和 基因畸变模式。2011年至2015年间检索了81个B细胞NHL组织块,并使用免疫组织化学以及 、 、 和 的间期FISH双色断裂分离探针进行研究。除 (p = 0.2)外,在所有 (p = 0.01)、 (p = 0.03)和 (p = 0.006)病例中,淋巴结和结外部位之间均检测到显著差异。我们的研究表明, 具有最高的基因易位,而 具有最多的增益拷贝和易位混合畸变,然而在 中未发现增益拷贝和易位的混合畸变。在弥漫性大B细胞淋巴瘤的生发中心B细胞(GCB)亚型中均未发现增益拷贝和易位的混合情况,然而,在非GCB亚型的 和 基因中发现了5例;而 基因的增益拷贝和易位混合病例仅在滤泡性淋巴瘤病例中发现。该研究发现了淋巴结和结外部位之间 、 和 基因畸变的有趣结果。这些信息可能有助于未来在马来西亚多民族人群以及亚洲人群中预测预后和确定有效治疗策略的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/115a/6930405/6af668e54f4b/jcav11p0190g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/115a/6930405/6af668e54f4b/jcav11p0190g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/115a/6930405/6af668e54f4b/jcav11p0190g001.jpg

相似文献

1
and Translocation in B-cell Non-Hodgkin Lymphoma Cases.以及B细胞非霍奇金淋巴瘤病例中的易位。
J Cancer. 2020 Jan 1;11(1):190-198. doi: 10.7150/jca.36954. eCollection 2020.
2
[Immunophenotyping and molecular genetic analysis of diffuse large B-cell lymphoma].弥漫性大B细胞淋巴瘤的免疫表型分析及分子遗传学分析
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2013 Apr;30(2):143-7. doi: 10.3760/cma.j.issn.1003-9406.2013.04.004.
3
Clinical Significance of , C-, and Genetic Abnormalities, Epstein-Barr Virus Infection, CD5 Protein Expression, Germinal Center B Cell/Non-Germinal Center B-Cell Subtypes, Co-expression of MYC/BCL2 Proteins and Co-expression of MYC/BCL2/BCL6 Proteins in Diffuse Large B-Cell Lymphoma: A Clinical and Pathological Correlation Study of 120 Patients.弥漫性大 B 细胞淋巴瘤中 、 、 和遗传异常、Epstein-Barr 病毒感染、CD5 蛋白表达、生发中心 B 细胞/非生发中心 B 细胞亚型、MYC/BCL2 蛋白共表达和 MYC/BCL2/BCL6 蛋白共表达的临床意义:120 例患者的临床与病理相关性研究。
Int J Med Sci. 2019 Apr 20;16(4):556-566. doi: 10.7150/ijms.27610. eCollection 2019.
4
Clinical significance of 'double-hit' and 'double-expression' lymphomas.“双打击”和“双表达”淋巴瘤的临床意义。
J Clin Pathol. 2020 Mar;73(3):126-138. doi: 10.1136/jclinpath-2019-206199. Epub 2019 Oct 15.
5
Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas.具有 BCL6 和 MYC 易位的双打击 B 细胞淋巴瘤是侵袭性的,常为结外淋巴瘤,与 BCL2 双打击 B 细胞淋巴瘤不同。
Am J Surg Pathol. 2013 Mar;37(3):323-32. doi: 10.1097/PAS.0b013e31826cebad.
6
MYC, BCL2, and BCL6 rearrangements in primary central nervous system lymphoma of large B cell type.原发性中枢神经系统弥漫性大 B 细胞淋巴瘤中 MYC、BCL2 和 BCL6 重排。
Ann Hematol. 2019 Jan;98(1):169-173. doi: 10.1007/s00277-018-3498-z. Epub 2018 Oct 11.
7
Colorectal diffuse large B-cell lymphoma: molecular subclassification and prognostic significance of immunoglobulin gene translocation.结直肠弥漫性大 B 细胞淋巴瘤:免疫球蛋白基因易位的分子分类和预后意义。
Hum Pathol. 2020 Feb;96:67-78. doi: 10.1016/j.humpath.2019.09.003. Epub 2019 Nov 15.
8
Clinicopathological and genomic analysis of double-hit follicular lymphoma: comparison with high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements.双打击滤泡淋巴瘤的临床病理和基因组分析:与伴有 MYC 和 BCL2 及/或 BCL6 重排的高级别 B 细胞淋巴瘤的比较。
Mod Pathol. 2018 Feb;31(2):313-326. doi: 10.1038/modpathol.2017.134. Epub 2017 Oct 6.
9
Molecular-cytogenetic characterization of non-Hodgkin's lymphoma with double and cryptic translocations of the immunoglobulin heavy chain gene.伴有免疫球蛋白重链基因双重及隐匿性易位的非霍奇金淋巴瘤的分子细胞遗传学特征
Leuk Lymphoma. 2004 Aug;45(8):1559-67. doi: 10.1080/10428190310001625674.
10
Interphase detection of immunoglobulin heavy chain gene translocations with specific oncogene loci in 173 patients with B-cell lymphoma.173例B细胞淋巴瘤患者免疫球蛋白重链基因与特定癌基因位点易位的间期检测
Cancer Genet Cytogenet. 2001 Aug;129(1):1-9. doi: 10.1016/s0165-4608(01)00436-8.

引用本文的文献

1
Comprehensive biomarker profiles in hematological malignancies: improving diagnosis, prognosis, and treatment.血液系统恶性肿瘤中的综合生物标志物谱:改善诊断、预后和治疗。
Biomark Med. 2025 Mar;19(6):223-238. doi: 10.1080/17520363.2025.2471745. Epub 2025 Feb 27.
2
Molecular Targets of Plant-Derived Bioactive Compounds in Oral Squamous Cell Carcinoma.植物源生物活性化合物在口腔鳞状细胞癌中的分子靶点
Cancers (Basel). 2024 Oct 26;16(21):3612. doi: 10.3390/cancers16213612.
3
Diffuse large B-cell lymphoma with cutaneous involvement in a patient with xeroderma pigmentosum type C.

本文引用的文献

1
pSTAT3 and MYC in Epstein-Barr virus-positive diffuse large B-cell lymphoma.爱泼斯坦-巴尔病毒阳性弥漫性大B细胞淋巴瘤中的磷酸化信号转导子和转录激活子3及原癌基因MYC
Malays J Pathol. 2019 Dec;41(3):273-281.
2
Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus.滤泡性淋巴瘤中存在 BCL2 基因位点断裂与无断裂时的临床特征相似。
Leukemia. 2016 Apr;30(4):854-60. doi: 10.1038/leu.2015.330. Epub 2015 Dec 1.
3
Reprogramming cell death: BCL2 family inhibition in hematological malignancies.重编程细胞死亡:血液系统恶性肿瘤中 BCL2 家族抑制。
一名患有C型着色性干皮病的患者发生皮肤受累的弥漫性大B细胞淋巴瘤。
JAAD Case Rep. 2024 May 7;49:28-31. doi: 10.1016/j.jdcr.2024.04.039. eCollection 2024 Jul.
4
Double‑hit primary lymphoma (MYC and BCL2) in the bilateral ovary: A case report.双侧卵巢双打击原发性淋巴瘤(MYC和BCL2):一例报告。
Oncol Lett. 2023 Feb 22;25(4):141. doi: 10.3892/ol.2023.13727. eCollection 2023 Apr.
5
Biallelic BCL6 rearrangements by dual t(3;14)(q27;q32) and t(3;22)(q27;q11) translocations in diffuse large B-cell lymphoma.双 t(3;14)(q27;q32)和 t(3;22)(q27;q11)易位导致弥漫性大 B 细胞淋巴瘤中 BCL6 双等位基因重排。
J Clin Exp Hematop. 2022;62(4):268-272. doi: 10.3960/jslrt.22031.
6
iRGD-modified exosomes-delivered BCL6 siRNA inhibit the progression of diffuse large B-cell lymphoma.整合素靶向肽iRGD修饰的外泌体递送的BCL6小干扰RNA抑制弥漫性大B细胞淋巴瘤的进展。
Front Oncol. 2022 Aug 2;12:822805. doi: 10.3389/fonc.2022.822805. eCollection 2022.
7
Dysregulation of Small Nucleolar RNAs in B-Cell Malignancies.B细胞恶性肿瘤中小核仁RNA的失调
Biomedicines. 2022 May 24;10(6):1229. doi: 10.3390/biomedicines10061229.
8
The biological function of the long non-coding RNA endogenous born avirus-like nucleoprotein in lung adenocarcinoma is mediated through the microRNA-655-3p/B-cell lymphoma-2 axis.长链非编码 RNA 内源性病毒样核蛋白在肺腺癌中的生物学功能是通过 microRNA-655-3p/B 细胞淋巴瘤-2 轴介导的。
Bioengineered. 2022 Apr;13(4):10679-10690. doi: 10.1080/21655979.2022.2065946.
Immunol Lett. 2013 Sep-Oct;155(1-2):36-9. doi: 10.1016/j.imlet.2013.09.015. Epub 2013 Oct 1.
4
Antigens in lymphoma development--current knowledge and future directions.淋巴瘤发生发展中的抗原——当前的认识和未来的方向。
Semin Cancer Biol. 2013 Dec;23(6):397-8. doi: 10.1016/j.semcancer.2013.09.003. Epub 2013 Sep 27.
5
Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification.理解 MYC 驱动的侵袭性 B 细胞淋巴瘤:发病机制和分类。
Blood. 2013 Dec 5;122(24):3884-91. doi: 10.1182/blood-2013-05-498329. Epub 2013 Sep 5.
6
MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma.MYC 状态与 BCL2 和 BCL6 表达的协同作用可预测弥漫性大 B 细胞淋巴瘤的结局。
Blood. 2013 Mar 21;121(12):2253-63. doi: 10.1182/blood-2012-06-435842. Epub 2013 Jan 18.
7
Growing importance of MYC/BCL2 immunohistochemistry in diffuse large B-cell lymphomas.MYC/BCL2免疫组化在弥漫性大B细胞淋巴瘤中的重要性日益凸显。
J Clin Oncol. 2012 Oct 1;30(28):3433-5. doi: 10.1200/JCO.2012.44.4729. Epub 2012 Sep 4.
8
Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.免疫组化双打击评分是利妥昔单抗联合环磷酰胺、多柔比星、长春新碱和泼尼松治疗弥漫性大 B 细胞淋巴瘤患者预后的强有力预测指标。
J Clin Oncol. 2012 Oct 1;30(28):3460-7. doi: 10.1200/JCO.2011.41.4342. Epub 2012 Jun 4.
9
Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab.弥漫性大 B 细胞淋巴瘤患者接受环磷酰胺、多柔比星、长春新碱和泼尼松联合利妥昔单抗治疗中 MYC、BCL2 和 BCL6 重排的预后意义。
Cancer. 2012 Sep 1;118(17):4173-83. doi: 10.1002/cncr.27396. Epub 2011 Dec 27.
10
Genotypic and phenotypic differences between nodal and extranodal diffuse large B-Cell lymphomas.结内和结外弥漫性大 B 细胞淋巴瘤的基因型和表型差异。
J Histochem Cytochem. 2011 Oct;59(10):918-31. doi: 10.1369/0022155411417309. Epub 2011 Aug 10.